Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype

Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype

Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the lack of expression of estrogen and progesterone receptors and amplification of human epidermal growth factor receptor 2 (HER2). Being the Epidermal Growth Factor Receptor (EGFR) highly expressed in mesenchymal TNBC...

Full description

Bibliographic Details
Main Authors: Nancy Nisticò, Annamaria Aloisio, Antonio Lupia, Anna Maria Zimbo, Selena Mimmi, Domenico Maisano, Rossella Russo, Fabiola Marino, Mariangela Scalise, Emanuela Chiarella, Teresa Mancuso, Giuseppe Fiume, Daniela Omodei, Antonella Zannetti, Giuliana Salvatore, Ileana Quinto, Enrico Iaccino
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cells
Subjects:
EGFR
triple-negative breast cancer
breast cancer biomarkers
peptide
phage display
tumor targeting
Online Access:https://www.mdpi.com/2073-4409/12/7/1078

Internet

https://www.mdpi.com/2073-4409/12/7/1078

Similar Items